AstraZeneca (AZN) Stock Plummets as Lung Cancer Trial Update Falls Short of Expectations
AstraZeneca PLC (NASDAQ: AZN) witnessed a dramatic 8.83% plunge in its share value on Monday following a disappointing update on […]
AstraZeneca (AZN) Stock Plummets as Lung Cancer Trial Update Falls Short of Expectations Read More »